Campaign Against Woodcock’s US FDA Commissioner Bid Has Begun
Executive Summary
Opioid issues delayed Robert Califf’s confirmation as FDA commissioner. Could they prevent the nomination of Janet Woodcock?
You may also be interested in...
Aduhelm Invades Senate Committee’s COVID-19 Hearing
Woodcock again defends the decision, saying Congress intended accelerated approval for those situations.
Like Sands Through The Hourglass, So Are Janet Woodcock’s Days As Acting FDA Commissioner
Janet Woodcock has been a no-nonsense acting commissioner, but there’s plenty of drama in the nomination process as opposition and support for her to become permanent head of the US FDA continues to mount while the wait for President Biden’s nominee drags on.
Like Sands Through The Hourglass, So Are The Days Of Woodcock’s Acting FDA Commissionership
Janet Woodcock has been a no-nonsense acting commissioner, but there’s plenty of drama in the nomination process as opposition and support for her to become permanent head of the US FDA continues to mount while the wait for President Biden’s nominee drags on.